These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28672959)

  • 21. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.
    Imada K; Shiota M; Kohashi K; Kuroiwa K; Song Y; Sugimoto M; Naito S; Oda Y
    Clin Cancer Res; 2013 Sep; 19(17):4638-50. PubMed ID: 23838318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
    Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.
    Li D; Liu X; Zhou J; Hu J; Zhang D; Liu J; Qiao Y; Zhan Q
    Hepatology; 2017 May; 65(5):1612-1627. PubMed ID: 28027578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eldecalcitol (ED-71), an analog of 1α,25(OH)
    Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
    Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
    J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
    Shiota M; Itsumi M; Yokomizo A; Takeuchi A; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    Prostate; 2014 Jun; 74(8):829-38. PubMed ID: 24729449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.
    Liu FF; Dong L; Yang X; Li DJ; Shen YY; Liu ZL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3867-3875. PubMed ID: 31115014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma.
    Wang X; Tao C; Yuan C; Ren J; Yang M; Ying H
    Mol Med Rep; 2017 Aug; 16(2):1964-1972. PubMed ID: 28656282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of BRD4 in squamous cell carcinoma and its effects on cell proliferation and invasion ability].
    Gao XZ; Li WC; Diao CY; Wang XH; Li SL
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):344-348. PubMed ID: 29783800
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
    Chen HQ; Gao D
    Int J Biochem Cell Biol; 2018 Jul; 100():22-29. PubMed ID: 29727714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
    Shiota M; Yokomizo A; Itsumi M; Uchiumi T; Tada Y; Song Y; Kashiwagi E; Masubuchi D; Naito S
    BJU Int; 2011 Jul; 108(2 Pt 2):E142-9. PubMed ID: 21083641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.
    Zarredar H; Pashapour S; Farajnia S; Ansarin K; Baradaran B; Ahmadzadeh V; Safari F
    J Cell Biochem; 2019 Jun; 120(6):10670-10677. PubMed ID: 30656741
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Li Y; Luan C
    Yonsei Med J; 2018 Dec; 59(10):1159-1165. PubMed ID: 30450849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.
    Basaki Y; Taguchi K; Izumi H; Murakami Y; Kubo T; Hosoi F; Watari K; Nakano K; Kawaguchi H; Ohno S; Kohno K; Ono M; Kuwano M
    Eur J Cancer; 2010 Mar; 46(5):954-65. PubMed ID: 20079629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
    Zhang H; Cheng S; Zhang M; Ma X; Zhang L; Wang Y; Rong R; Ma J; Xia S; Du M; Shi F; Wang J; Yang Q; Bai X; Leng J
    Int J Oncol; 2014 Mar; 44(3):769-80. PubMed ID: 24378923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
    Poudel B; Lee YM; Kim DK
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.